VIVS

VivoSim Labs, INC.

Healthcare · Biotechnology

$341.34 sample

+5.59 (+1.66%) 1D

Market cap

$926.5B

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$341.34 +12.74% 3M daily closessample

341.34298.38

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: General Counsel
Oct 02INSInsider buy: Director
Sep 25INSInsider sell: 10% owner
Sep 16INSInsider sell: Director
Sep 07INSInsider sell: Chief Executive Officer
Sep 01INSInsider buy: Chief Executive Officer
Aug 27INSInsider buy: General Counsel
Aug 20INSInsider sell: Chief Executive Officer

Sign up to see the real VIVS record →

Company facts

SEC EDGAR registration

Name: VivoSim Labs, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -2sample, -100 to +100
Reporting currency: USD

Who is positioning in VIVS

sample

Insiders: 28 insider transactions over 90 days, net selling, $98.9M
Congress: 1 members traded over 90 days
Institutions · 13F: 36 funds hold $11.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$50.4B +18.0% y/y

Q4 2024Q3 2026

Inventory$30.3B +10.7% y/y

Q4 2024Q3 2026

Accounts receivable$22.0B +12.5% y/y

Q4 2024Q3 2026

Total debt$61.8B +18.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $275.7B -7.4% 3M
Sample peer B: $500.5B +13.2% 3M
Sample peer C: $899.1B -12.8% 3M
Sample peer D: $721.7B +7.0% 3M
Sample peer E: $129.0B -7.8% 3M